These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31504056)

  • 1. Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).
    Moreira HS; Costa AS; Machado Á; Castro SL; Lima CF; Vicente SG
    PLoS One; 2019; 14(9):e0221873. PubMed ID: 31504056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): normative values from a healthy sample and clinical utility in Alzheimer's disease.
    Moreira HS; Lima CF; Vicente SG
    J Alzheimers Dis; 2014; 42(1):261-73. PubMed ID: 24840570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the INECO Frontal Screening and the Frontal Assessment Battery in detecting executive dysfunction in early-onset cognitive impairment and dementia.
    Heikkinen AL; Tikkanen V; Hänninen T; Hublin C; Koivisto AM; Saari TT; Remes AM; Paajanen TI; Krüger J
    J Int Neuropsychol Soc; 2024 May; 30(4):339-349. PubMed ID: 37800312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Accuracy of INECO Frontal Screening in the Diagnosis of Executive Dysfunction in Frontotemporal Dementia and Alzheimer Disease.
    Bahia VS; Cecchini MA; Cassimiro L; Viana R; Lima-Silva TB; de Souza LC; Carvalho VA; Guimarães HC; Caramelli P; Balthazar MLF; Damasceno B; Brucki SMD; Nitrini R; Yassuda MS
    Alzheimer Dis Assoc Disord; 2018; 32(4):314-319. PubMed ID: 29734264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INECO Frontal Screening (IFS): a brief, sensitive, and specific tool to assess executive functions in dementia.
    Torralva T; Roca M; Gleichgerrcht E; López P; Manes F
    J Int Neuropsychol Soc; 2009 Sep; 15(5):777-86. PubMed ID: 19635178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Time-sparing screening method for mild cognitive impairment and early Alzheimer's disease: Self- and family reports using the TMIG index of competence].
    Akasaka H; Yonezawa H; Takahashi J; Obara S; Shibata T; Suzuki M; Ishizuka N; Sato M; Kudo M; Terayama Y; Maeda T
    Nihon Ronen Igakkai Zasshi; 2020; 57(2):182-194. PubMed ID: 32475946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.
    Amaral-Carvalho V; Bento Lima-Silva T; Inácio Mariano L; Cruz de Souza L; Cerqueira Guimarães H; Santoro Bahia V; Nitrini R; Tonidandel Barbosa M; Sanches Yassuda M; Caramelli P
    J Alzheimers Dis; 2024; 100(s1):S45-S55. PubMed ID: 39031367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.
    Alegret M; Peretó M; Pérez A; Valero S; Espinosa A; Ortega G; Hernández I; Mauleón A; Rosende-Roca M; Vargas L; Rodríguez-Gómez O; Abdelnour C; Berthier ML; Bak TH; Ruíz A; Tárraga L; Boada M
    J Alzheimers Dis; 2018; 62(2):611-619. PubMed ID: 29480180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of the INECO Frontal Screening for detecting Mild Cognitive Impairment in Parkinson's disease.
    Broche-Pérez Y; Bartuste-Marrer D; Batule-Domínguez M; Toledano-Toledano F
    Dement Neuropsychol; 2019; 13(4):394-402. PubMed ID: 31844492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of verbal fluency tests in the discrimination of mild cognitive impairment and probable Alzheimer's disease in older Spanish monolingual individuals.
    García-Herranz S; Díaz-Mardomingo MC; Venero C; Peraita H
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Nov; 27(6):826-840. PubMed ID: 31822214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease.
    Conca F; Esposito V; Catricalà E; Manenti R; L'Abbate F; Quaranta D; Giuffrè GM; Rossetto F; Solca F; Orso B; Inguscio E; Crepaldi V; De Matteis M; Rotondo E; Manera M; Caruso G; Catania V; Canu E; Rundo F; Cotta Ramusino M; Filippi M; Fundarò C; Piras F; Arighi A; Tiraboschi P; Stanzani Maserati M; Pardini M; Poletti B; Silani V; Marra C; Di Tella S; Cotelli M; Lodi R; Tagliavini F; Cappa SF
    Alzheimers Res Ther; 2024 May; 16(1):98. PubMed ID: 38704608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.
    Yatawara C; Lim L; Chander R; Zhou J; Kandiah N
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.
    Roalf DR; Moberg PJ; Xie SX; Wolk DA; Moelter ST; Arnold SE
    Alzheimers Dement; 2013 Sep; 9(5):529-37. PubMed ID: 23260866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.